HMGB1 and TLR4 as biomarkers for osteoporosis risk in type 2 diabetes mellitus: a cross-sectional study
Abstract Background This study explored the application value of high mobility group box 1 (HMGB1) and toll-like receptor 4 (TLR4) levels in the diagnosis of type 2 diabetes mellitus (T2DM) with osteoporosis (OP). Methods This was a cross-sectional study of 126 patients. The patients with T2DM was s...
Saved in:
| Main Authors: | Guang Zhu, Chunting Kan, Changchun Cao, Hong Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Endocrine Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12902-025-01998-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury
by: Sayantap Datta, et al.
Published: (2025-01-01) -
Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model
by: Sang-A. Oh, et al.
Published: (2025-02-01) -
Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway
by: Qiongyin Zhang, et al.
Published: (2025-08-01) -
An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
by: Kari Ann Shirey, et al.
Published: (2025-02-01) -
HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy
by: Yi-Fang Zhong, et al.
Published: (2025-05-01)